Goal: To investigate the prevalence of eating disorder (ED) symptoms among Mexican adults with irritable bowel syndrome (IBS).
Background: The relationship between IBS and EDs is complex, yet understudied, particularly in Latin America.
Methods: In this cross-sectional study, 369 Mexican adults (18 to 69 y), comprising 133 IBS patients and 236 healthy controls (HCs), were evaluated using the Rome IV criteria, The Spanish version of the Eating Disorder Examination Questionnaire (S-EDE-Q), the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) and the Hospital Anxiety and Depression Scale (HADS). Statistical analysis included the Student t test or the Wilcoxon Rank-sum test for group comparisons, the Kruskal-Wallis test for multiple comparisons, and logistic regression, with a significance threshold set at a P-value of <0.05.
Results: IBS individuals were at an increased risk for clinically significant S-EDE-Q when compared with HCs (12.8% vs. 3.8%, odds ratio OR 3.6, 95% CI: 1.5-8.5; P=0.001), especially among younger individuals. IBS individuals displayed a higher risk for dietary restraint and heightened concerns about eating, body shape, and weight. In addition, binge-eating episodes occurred more frequently within the IBS group. Notably, there were no significant differences in body mass index between individuals with clinically significant S-EDE-Q and those with normal scores. IBS individuals with severe symptoms had higher S-EDE-Q scores; furthermore, those with IBS and clinically significant S-EDE-Q exhibited higher levels of anxiety and depression.
Conclusions: Our study reveals a significantly higher risk for ED in IBS individuals compared with HCs. This highlights the crucial importance of conducting ED screenings before dietary interventions, particularly among younger individuals and those displaying elevated levels of anxiety and depression.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MCG.0000000000002101 | DOI Listing |
Gastroenterology
March 2025
Department of Pediatrics, St Antonius Hospital, Nieuwegein, The Netherlands.
Background And Aims: Pediatric irritable bowel syndrome (IBS) and functional abdominal pain - not otherwise specified (FAP-NOS) lack effective pharmacologic interventions. We evaluated the efficacy of mebeverine, an antispasmodic agent, and the effect of labeling within a pediatric cohort.
Methods: This randomized trial was conducted across 13 hospitals.
J Clin Gastroenterol
March 2025
Department of Psychology, University of Pennsylvania, Philadelphia, PA.
Goals: To test the efficacy of a self-help cognitive behavioral therapy (CBT) for irritable bowel syndrome (IBS) app compared with an active control app.
Background: IBS is a disorder of gut-brain interaction that can result in significant distress, disability, and psychiatric co-morbidity. CBT is an effective treatment for IBS.
Rev Esp Enferm Dig
March 2025
School of Traditional Chinese Medicine, Ningxia Medical University.
Background And Aims: The relationship between irritable bowel syndrome (IBS) and structural changes in various regional cortical areas remains unclear. Mendelian randomization (MR) was used to explore the potential association between IBS and Structural Brain Changes.
Methods: Genetically independent loci associated with IBS in individuals of European ancestry were selected as instrumental variants (IVs) in the large-scale genome-wide association studies (GWAS).
Front Neurosci
February 2025
Social Brain and Development Lab, School of Psychology, University of Surrey, Guildford, United Kingdom.
Post-traumatic stress disorder (PTSD) is a common mental health disorder that can occur following exposure to a traumatic event, and is characterized by symptoms including intrusive memories, dissociation, and nightmares. PTSD poses significant suffering on the individual and can reduce quality of life substantially, however, its mechanisms are not fully understood. It has also been associated with gut abnormalities, such as with irritable bowel syndrome, indicating possible involvement of the gut microbiome and gut-brain axis.
View Article and Find Full Text PDFJ Adv Res
March 2025
Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, Jilin, China. Electronic address:
Introduction: Observational studies have shown that gallstone disease (GSD), cholecystitis, cholangitis, polyp of gallbladder, viral hepatitis, pancreatitis and gastrointestinal (GI) traits such as H. pylori infection, inflammatory bowel disease, and digestive ulcer are associated with the risk of biliary tract cancer (BTC). However, no study has explored their causal associations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!